Apart from breast cancer, EPHA2 overexpression has also been associated with poor prognosis in several other types of malignant tumors including ovarian, cervical, colorectal, vulvar, gastric, lung, oral, endometrial, esophageal, renal cell carcinomas, and gliomas [48,49,50,51,52,53,54,55,56,57,58]. Here, EPHA2 is linked to renal cell carcinoma.